Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Steroid Withdrawal in Pediatric Kidney Transplant Recipients
NCT00023244Phase 2Terminated
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Jan 2001
- Primary completion
- Jun 2005
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
Phase 2, randomised, double-blind trial of prednisone in end stage renal disease (ESRD) (2 arms), sponsored by National Institute of Allergy and Infectious Diseases. Primary endpoint: Change in standardized height at 2.5 years. Started Jan 2001; status: terminated.
02
Drugs
prednisone
03
Conditions
end stage renal disease (ESRD)
Beyond the preview
Go deeper on NCT00023244.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00023244.